Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial
1 other identifier
interventional
108
1 country
1
Brief Summary
The aim of this study is to test the hypothesis that addition of dexmedetomidine to fentanyl-based intravenous patient controlled analgesia (PCA) reduces requirement of fentanyl bolus and consequent postoperative nausea and vomiting in high-risk patients undergoing lumbar spine surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 17, 2013
CompletedFirst Posted
Study publicly available on registry
April 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFebruary 7, 2014
February 1, 2014
1 year
April 17, 2013
February 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
total dose and bolus administration of opioid
After induction of anesthesia, peak velocity of carotid artery blood flow is measured by the pulsed wave Doppler signal obtained from the left common carotid artery. Respirophasic variation of the peak velocity is defined as the difference between the maximum and the minimum values of peak velocity divided by the mean of the two values during one respiratory cycle. Fluid responder is defined as a patient whose stroke volume index is increased ≥15% after volume expansion. The receiver operating characteristic curve analysis to discriminiate fludi responder is performed.
an expected average of 48 hrs for requirements of total dose and number of bolus administration of PCA
Secondary Outcomes (1)
consequent postoperative nausea and vomiting
an expected average of 48 hrs for assessing of the 11-points verbal numerical rating scales
Study Arms (2)
dexmedetomidine
EXPERIMENTALaddition of dexmedetomidine to fentanyl-based intravenous patient controlled analgesia (PCA)
normal saline
PLACEBO COMPARATORnormal saline as a placebo
Interventions
Eligibility Criteria
You may qualify if:
- \. female, non-smoking patient who are 20-65 of age scheduled for elective lumbar spine surgery
You may not qualify if:
- Bradycardia on EKG (45bpm)
- Atrioventricular conduction disorder
- Uncontrolled hypertension
- angina history
- obesity (BMI ≥ 30 kg/m2)
- Preoperative administration of opioid
- Preoperative administration of antiemetics
- Gastrointestinal disorder history
- Hepatic or renal disease
- Pregnant 11. Foreigner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yonsei University College of Medicine
Seoul, Seoul, 120-752, South Korea
Related Publications (1)
Song Y, Shim JK, Song JW, Kim EK, Kwak YL. Dexmedetomidine added to an opioid-based analgesic regimen for the prevention of postoperative nausea and vomiting in highly susceptible patients: A randomised controlled trial. Eur J Anaesthesiol. 2016 Feb;33(2):75-83. doi: 10.1097/EJA.0000000000000327.
PMID: 26258655DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2013
First Posted
April 25, 2013
Study Start
September 1, 2012
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
February 7, 2014
Record last verified: 2014-02